Health Systems in Transition - Hungary - World Health Organization ...
Health Systems in Transition - Hungary - World Health Organization ...
Health Systems in Transition - Hungary - World Health Organization ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Health</strong> systems <strong>in</strong> transition <strong>Hungary</strong> 147<br />
Table 5.1<br />
Number and ma<strong>in</strong> types of pharmacies <strong>in</strong> <strong>Hungary</strong>, 2000–2010 (selected years)<br />
Type of pharmacy 2000 2006 2008 2009<br />
2010<br />
(23 August) a<br />
Public 1 999 2 010 2 351 2 412 2 441<br />
– branch pharmacy 604 650 652 655 650<br />
– s<strong>in</strong>gle-handed pharmacy 298 278 253 248 250<br />
Institutional (hospital) 147 143 130 130 122<br />
– with a community retail unit 46 73 71 74 80<br />
Sources: HCSO, 2010f; a Government of the Republic of <strong>Hungary</strong>, 2010b.<br />
Note: S<strong>in</strong>gle-handed pharmacies are translated <strong>in</strong> the HCSO, 2010f publication as “magistral pharmacies”, but this is <strong>in</strong>correct because<br />
these pharmacies do not dispense magistral products.<br />
In addition to the types of pharmacies shown <strong>in</strong> Table 5.1, there are three<br />
other categories of pharmaceutical retail (Government of the Republic of<br />
<strong>Hungary</strong>, 2010b). First, the over-the-counter market was liberalized <strong>in</strong> 2006<br />
by allow<strong>in</strong>g the sale of certa<strong>in</strong> over-the-counter drugs outside of pharmacies<br />
(2006/8). In 2010, about 470 types of over-the-counter medic<strong>in</strong>es were available<br />
<strong>in</strong> about 600 retail units (mostly petrol stations, supermarkets, drug stores and<br />
beauty shops); only 1% of total over-the-counter retail sales took place <strong>in</strong> such<br />
locations, however. Second, through the active <strong>in</strong>patient care sub-budget of the<br />
HIF, the NHIFA is the direct purchaser of certa<strong>in</strong> very expensive drugs (e.g.<br />
target therapies <strong>in</strong> oncology such as trastuzumab, bevacizumab and pemetrexed),<br />
which are supplied to hospitals by the manufacturers on a contractual basis, as<br />
part of which the NHIFA stipulates the number of patients that can be treated.<br />
Approximately 3–4% of the pharmaceutical sub-budget of the HIF is spent<br />
this way. Third, only a very small fraction of pharmaceutical retail takes place<br />
through the <strong>in</strong>ternet and home delivery, which is still operated by pharmacies.<br />
Before 2006 the ownership and market structure of pharmaceutical<br />
retail was developed based on the ethical model of corporate responsibility.<br />
Privatization was guided by Act LIV of 1994 on the Establishment and Rules<br />
of Operation of Pharmacies, accord<strong>in</strong>g to which only self-employed private<br />
entrepreneurs and limited partnerships were allowed to operate community<br />
pharmacies, with the additional requirement that the unlimited liability<br />
partners of the limited partnerships must be pharmacists with at least a 25%<br />
share (Article 36). Community pharmacies had to be established and managed<br />
by pharmacists with a special licence, the so-called personal right (személyi<br />
jog) (Article 15), a concept similar to the “practice right” <strong>in</strong> primary care (see<br />
section 5.3). In partnerships, one of the unlimited liability partners had to<br />
be a pharmacist <strong>in</strong> possession of this special licence (Article 29). With these<br />
measures, the government aimed to ensure that pharmacists had a decisive role